Davidson T A, Rubenfeld G D, Caldwell E S, Hudson L D, Steinberg K P
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Harborview Medical Center, University of Washington School of Medicine, Seattle, Washington 98104-2499, USA.
Am J Respir Crit Care Med. 1999 Dec;160(6):1838-42. doi: 10.1164/ajrccm.160.6.9903058.
Despite a great deal of information about the risk factors, prognostic variables, and hospital mortality in the acute respiratory distress syndrome (ARDS), very little is known about the long-term outcomes of patients with this syndrome. We conducted a prospective, matched, parallel cohort study with the goals of describing the survival of patients with ARDS after hospital discharge and comparing the long-term survival of patients with ARDS and that of a group of matched controls. The study involved 127 patients with ARDS associated with trauma or sepsis and 127 controls matched for risk factor (trauma or sepsis) and severity of illness who survived to hospital discharge. Time until death was used as the outcome measure. Survival was associated with age, risk factor for ARDS, and comorbidity. There was no difference in the long-term mortality rate for ARDS patients and that of matched controls (hazard ratio for ARDS: 1.00; 95% confidence interval: 0.47 to 2.09) after controlling for age, risk factor for ARDS, comorbidity, and severity of illness. We conclude that if sepsis or trauma patients survive to hospital discharge, ARDS does not increase their risk of subsequent death. Older patients, patients with sepsis, and patients with comorbidities, regardless of the presence of ARDS, have a higher risk of death after hospital discharge. For the purposes of clinical prognosis and cost-effectiveness analysis, the long-term survival of patients with ARDS can be modeled on the basis of age, underlying risk factor for ARDS, and comorbidity.
尽管关于急性呼吸窘迫综合征(ARDS)的危险因素、预后变量和医院死亡率已有大量信息,但对于该综合征患者的长期预后却知之甚少。我们进行了一项前瞻性、匹配、平行队列研究,旨在描述ARDS患者出院后的生存情况,并比较ARDS患者与一组匹配对照的长期生存率。该研究纳入了127例与创伤或脓毒症相关的ARDS患者以及127例因危险因素(创伤或脓毒症)和疾病严重程度匹配且存活至出院的对照。将直至死亡的时间用作结局指标。生存与年龄、ARDS的危险因素及合并症相关。在控制年龄、ARDS的危险因素、合并症和疾病严重程度后,ARDS患者与匹配对照的长期死亡率无差异(ARDS的风险比:1.00;95%置信区间:0.47至2.09)。我们得出结论,若脓毒症或创伤患者存活至出院,ARDS不会增加其随后死亡的风险。老年患者、脓毒症患者和合并症患者,无论是否存在ARDS,出院后死亡风险均较高。为了临床预后和成本效益分析的目的,ARDS患者的长期生存情况可根据年龄、ARDS的潜在危险因素和合并症进行建模。